Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
Brief Summary: This prospective trial aims to determine if enhanced prostate imaging using two novel imaging technologies (high resolution DWI and 18F-PSMA PET-MRI) will detect prostate cancers not seen on standard multiparametric prostate MRI in patients considered candidates for focal HIFU.
Sponsor:
Progenics Pharmaceuticals
Phase:
Phase 2
Government Study Link:
NCT04461509 - Click here to see study onClinicalTrials.gov
Help us improve your experience